Corona Remedies IPO Opens Strong: High GMP And Long-Term ‘Subscribe’ Rating Boost Investor Interest- Here’s Everything You Need To Know
Corona Remedies IPO opens with strong investor buzz, driven by solid brand strength, high GMP, and long-term growth potential. Though…
